It was great spending time with pharma colleagues who have similar issues and challenges.
Jennifer MerrickInteractive Marketing Manager
Roche
- Why oncology market access models must evolve
The proliferation of stakeholders makes oncology market access increasingly complex—and successful models increasingly essential. Peter Mansell reports.
9:59am, 7th Sep 2010 - Comprehensive strategies for market access
Alan Crofts outlines the flexible market access strategies needed to address the needs of clinical and non-clinical decision makers.
9:51am, 7th Sep 2010 - Market access: Risk sharing and alternative pricing schemes
Shared-risk agreements can represent uncertain rewards for drug makers and payers. What you need to know before entering into one.
2:33pm, 10th Aug 2010
All Testimonials
A great opportunity to exchange and gain best practices and get inspired.Global Brand Manager, Novartis
Excellent for getting a good overview on key trends in the industry.Global Product & Strategic Accounts Director, Solvay
Distilled business knowledge from the frontline experts.Portfolio & Planning Manager, GlaxoSmithKline
eyeforpharma events never fail to deliver.Senior Vice President, Bayer Healthcare
Great and very useful meeting. The speakers were excellent and the content was relevant. Looking forward to the next meeting.Ruth Clements, Director, Bayer
I learned a tremendous amount and thought your speakers, moderators and panelists were very high quality. Thank you very much for putting together an informative session.Leslie Heyison, Director, Pfizer
It was great spending time with pharma colleagues who have similar issues and challenges.Jennifer Merrick, Interactive Marketing Manager, Roche
Overall, I thought the conference was excellent. Good mix of presentations and great networking opportunities.Gwen Clarke, Procter and Gamble
A good event drawing a good cross functional group together.Steve Richmond, AstraZeneca
Great event, with current, interesting and informative talks.David McCormick, Novartis Pharmaceuticals
A very useful event, covering a lot of interesting topics and a good audience with varying experience.Charlotte Eastlake, Boehringer Ingelheim
Good job -- as an exhibitor, everything went well.Marlene L Galante, Chief Client Officer, Physicians Interactive
